Skip to main content
Cian Healthcare Limited logo

Cian Healthcare Limited — Investor Relations & Filings

Ticker · 542678 ISIN · INE05BN01027 LEI · 894500RS7FBEWD2XYR82 BSE.NS Manufacturing
Open in API
Filings indexed 5 across all filing types
Latest filing 2026-05-30 Regulatory Filings
Country IN India
Listing BSE.NS 542678

About Cian Healthcare Limited

https://cian.co/

Cian Healthcare Limited specializes in the development, manufacturing, and marketing of a diverse range of healthcare products. The company operates advanced facilities producing various dosage forms, including tablets, capsules, liquid orals, ointments, and nutraceuticals. Its product portfolio spans multiple therapeutic segments such as orthopedics, gynecology, pediatrics, dermatology, and cardiology. In addition to proprietary brands, the organization provides comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company emphasizes adherence to international quality standards, utilizing WHO-GMP certified processes to ensure the efficacy and safety of its formulations. It focuses on expanding market presence through continuous product innovation and a robust distribution network catering to diverse healthcare requirements.

Recent filings

Filing Released Lang Actions
As per the Attachment
Regulatory Filings Classification · 72% confidence The document is a formal announcement to the stock exchange under SEBI Listing Regulation 30, disclosing the outcome of a Board meeting and the resolutions approved (e.g., proposals for shareholder postal ballot on related‐party transactions, borrowing limits, director appointments, etc.). It is not the full report itself, nor an actual proxy or notice text, but a regulatory disclosure of board decisions. This aligns with a general regulatory announcement (RNS) rather than a detailed financial report or specific category like MANG (which covers only definitive board/management changes) or PSI (which would be the actual voting materials).
2026-05-30 English
Cian Healthcare Limited, in its board meeting dated May 30, 2026, has approved the audited financial results (Standalone and Consolidated) along with Audit Report and Statement on Impact ....
Audit Report / Information Classification · 83% confidence The document is a stock-exchange filing under SEBI LODR Regulations 30/33, reporting the Board’s approval of the Audited Financial Results for the half‐year and year ended March 31, 2026, and includes the full Independent Auditor’s Report with a qualified conclusion. It is not a full Annual Report or management-change notice, nor merely a brief release, but is specifically a standalone audit report on the financial results, matching the “Audit Report / Information” definition. FY 2026
2026-05-30 English
Outcome of the Board Meeting of Cian Healthcare Limited held on May 30, 2026- Audited Financial Results (Standalone and Consolidated) for the half-year and Financial Year ended March 31, 2026.
Interim / Quarterly Report Classification · 86% confidence The document is a formal SEBI/BSE regulatory filing detailing the outcome of the Board meeting held on May 30, 2026, specifically approving and submitting the audited standalone and consolidated financial results for the half‐year and financial year ended March 31, 2026. It includes the full audited financial statements (assets & liabilities, cash flows) and the Independent Auditor’s Report with modified opinions. This is not a mere publication announcement (it exceeds a trivial length and embeds the full data), nor is it a full Annual Report (no narrative MD&A or broader annual disclosures), nor simply an audit letter. It is a comprehensive interim financial report covering the six‐month period (along with year‐end results) and contains substantive financial data. Therefore, it best fits the “Interim / Quarterly Report (IR)” category. FY 2026
2026-05-30 English
Non-Applicability of Annual Secretarial Compliance Report for the Financial Year Ended March 31, 2026, as the Company is listed on the SME Platform of BSE Limited.
Regulatory Filings Classification · 78% confidence The document is a formal letter to the stock exchange (BSE) under SEBI Listing Regulations, informing non-applicability of the Annual Secretarial Compliance Report. It is a compliance/regulatory disclosure rather than a full report, management commentary, dividend notice, or other specific category. Therefore, it falls under general regulatory filings (RNS).
2026-05-29 English
Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Audited Financial Results ....
Regulatory Filings Classification · 85% confidence The document is an intimation under SEBI Listing Regulations informing the exchange of a forthcoming Board of Directors meeting to consider and approve audited financial results. It contains no actual financial statements or published reports, nor does it announce a result or change in directors—it is a routine compliance notice to the stock exchange. There is no substantive management discussion, proxy materials, or financial data. Therefore it falls under the general regulatory announcement category: Regulatory Filings (RNS).
2026-05-26 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.